Section 280E: The Definition First
In plain English: Section 280E usually stops businesses from getting deductions or credits, for money spent on selling drugs listed in Schedule I or II.
The federal schedule is important, for the analysis. Does not by itself answer the accounting question.
A cannabis business must figure out the activity, how it calculates inventory and cost of goods sold which expenses belong to that activity and whether separate cannabis business lines need treatment. Those four questions are the foundation of cannabis tax planning. Provide me in one line.
The Two Routes in 2026
The federal picture changed materially in April 2026.
The DOJ and DEA moved FDA-approved marijuana products and marijuana products under qualifying state-issued medical-marijuana licenses into Schedule III.
The overall plan, for shifting marijuana from Schedule I to Schedule III remains a separate process.
Route 1: Activity still involving Schedule I or II
If the activity continues to involve a Schedule I or II controlled substance and the other requirements of §280E are met, the provision can still disallow deductions and credits connected with that activity.
For cannabis tax planning, that changes the order of the questions.
Before asking which expenses may be deductible, the business first needs to identify the activity being analyzed and the federal schedule that applies to it.
Route 2: Qualifying medical activity now in Schedule III
For activity covered by the April 2026 medical-marijuana action, the §280E analysis changes because the relevant product or activity is no longer in Schedule I or II.
Treasury and the IRS said the rescheduling generally removes §280E as a bar for businesses that, because of the final order, no longer traffic in Schedule I or II substances.
They also announced expected guidance for businesses with multiple activities and a transition rule tied to the taxable year containing the order’s effective date.
That guidance should be checked again before a return is finalized.
In the meantime, the books should preserve enough activity-level detail to support the analysis rather than relying on a single blanket “cannabis” classification.
The Terms You Will Meet
What Section 280E Changes in the Books
Tax accounting for cannabis business owners should begin with the operating records, not with a year-end effort to reclassify expenses.
For activity still subject to §280E, IRS Chief Counsel has explained that COGS is used in determining gross income and is different from an ordinary deduction.
Its analysis also distinguishes inventory treatment for resellers and producers under applicable §471 rules.
A practical accounting flow is:
Classify the product and activity.
Map the inventory and production function.
Calculate supportable COGS under the applicable inventory method.
Could you separate operating expenses from inventory costs.
Tie the accounting workpapers directly to the tax return.
The main thing is to keep the books and the operation in line, with each other.
Costs must match what really happened in the business and Costs must follow the rules that the accounting system says are necessary.
They should not be moved into COGS simply because a COGS classification produces a better tax result. Sound cannabis tax planning works from the records forward, not from the desired result backward.
The Four Facts That Answer Most 280E Questions
Most questions, about section 280e deductions can be answered once four facts are known.
| Fact to establish | Why it matters |
|---|---|
| What product or activity is involved? | Determines whether Schedule I/II treatment may still be relevant |
| Is the business a reseller, producer or both? | Affects which inventory-cost framework must be considered |
| How are inventory and production costs supported? | Determines whether COGS can be traced to actual operations |
| Does the business have medical, adult-use or other distinct activities? | I can create activity level accounting and apportionment questions for you. |
The Questions Cannabis Operators Actually Ask
Section 280E is a federal tax rule that disallows deductions and credits for qualifying trades, businesses or activities involving trafficking in controlled substances listed in Schedule I or II.
Its wording is tied to those schedules.
That is why a change in the federal classification of a product or activity can change the tax analysis.
When §280E applies, ordinary business expenses can receive very different tax treatment.
Expenses that would normally be considered under general business-deduction rules may be disallowed for affected activity.
Tax accounting for a cannabis business therefore needs to distinguish legitimate inventory costs from operating expenses instead of treating every cash outflow as though it has the same tax character.
The accurate answer is: it depends on the activity.
Qualifying medical-marijuana activity covered by the April 2026 federal action moved to Schedule III.
Other marijuana activity was not automatically moved with it, and broader marijuana rescheduling remains a separate proceeding.
The April 2026 action covers FDA-approved products containing marijuana and marijuana products subject to qualifying state-issued medical-marijuana licenses.
The scope of the federal order matters.
A business should not assume that every marijuana product or every state-authorized activity received Schedule III treatment.
The April medical-marijuana order did not automatically move state adult-use marijuana activity into Schedule III.
Where adult-use activity continues to involve a Schedule I substance and §280E’s other conditions are met, the provision can remain relevant.
Broader federal rescheduling should be monitored separately rather than assumed in advance.
COGS is part of the calculation used to determine gross income from merchandise sales.
In simplified terms, gross receipts are reduced by COGS before ordinary business deductions are considered.
IRS Chief Counsel has specifically distinguished this gross-income calculation from deductions disallowed by §280E.
A reseller generally looks to the applicable inventory-cost rules for the cost of merchandise acquired for resale and other qualifying inventory costs.
The goal is not to build the largest possible COGS number.
The records should show which costs actually belong to acquiring and holding inventory under the applicable method.
A producer’s analysis differs because production costs become part of the inventory question.
Direct materials, direct labor and qualifying production-related costs may be relevant under the applicable inventory rules.
Selling, administrative or other costs do not become production costs simply because recovering them through COGS would produce a better tax result.
A portion of a cost may sometimes support production, while another portion supports selling, administration or another function.
The account name alone does not determine the treatment.
The business needs a supportable connection between the cost, the work performed and the applicable inventory rule.
Section 263A should not be treated as a way to convert expenses otherwise disallowed by §280E into recoverable inventory costs.
IRS Chief Counsel specifically rejected that approach in its cannabis inventory memorandum.
Likewise, this guide does not treat §471(c) as a blanket authorization to expand cannabis COGS.
Any position should be evaluated against the current Code, regulations and guidance rather than used as an automatic tax shortcut.
The books should make the activities distinguishable without requiring a year-end reconstruction.
Revenue, inventory, direct costs and shared expenses should be captured with enough detail to support whichever allocation or apportionment method ultimately applies.
Treasury and the IRS have specifically identified multiple-activity expense apportionment as an area for guidance following the 2026 medical rescheduling.
A genuinely separate trade or business can require separate analysis, but the conclusion depends on the facts.
Creating a second legal entity, department or general-ledger account does not automatically remove §280E from activity that remains within its scope.
The underlying operations and records still need to support the distinction.
In tax accounting for a cannabis business, the supporting file should connect the tax treatment back to the actual business records.
Depending on the operation, that may include invoices, inventory records, production reports, labor or time support, allocation workpapers, reconciliation schedules, general-ledger detail and documentation showing how shared costs were assigned.
Current cannabis tax planning should start with accurate activity classification, supportable COGS, reliable inventory records, reconciled books and a clear understanding of which expenses belong to which operation.
For businesses with both medical and adult-use activity, the accounting should also be ready to support current Treasury/IRS guidance as it develops rather than waiting until filing season to recreate the underlying facts.
Six Things That Are Not True About Section 280E
Several widely repeated claims about Section 280E deductions do not hold up.
- “Every cannabis business is subject to 280E.” Not as a blanket statement in 2026. The analysis depends on the activity and the federal schedule that applies.
- “Medical marijuana is federally legal now.” Schedule III treatment is not the same thing as removing federal controlled-substance regulation.
- “COGS is just another tax deduction.” COGS is part of determining gross income and should be analyzed separately from ordinary deductions.
- “Any overhead can be moved into COGS.” Cost treatment follows the function performed and the applicable inventory rules, not the preferred tax outcome.
- “Section 263A lets us capitalize otherwise disallowed expenses.” IRS Chief Counsel has specifically rejected using §263A to transform costs that otherwise could not be taken into account.
- “A separate entity automatically avoids 280E.” Entity labels alone do not establish separate tax treatment. The underlying activities and facts remain central.
The more useful question is not, “How much expense can we move into COGS?” It is, “What does the operating record actually support?” Clear inventory records, cost classifications reconciled source systems and documented allocation logic improve accounting usefulness for management and readiness, for tax filing.
Sources & further reading
- 26 U.S.C. §280E Expenditures in connection with the illegal sale of drugs. uscode.house.gov
- U.S. Department of Justice April 2026 medical-marijuana Schedule III action. justice.gov
- U.S. Treasury / IRS tax guidance process after the DOJ final order. home.treasury.gov
- DEA broader marijuana rescheduling regulatory actions. dea.gov
- IRS Office of Chief Counsel Memorandum 201504011 on §280E, COGS, §471 and §263A. irs.gov
CrownGlobe provides accounting, bookkeeping and tax-related services. This article offers information only and is not legal, tax, investment or regulatory advice. Cannabis tax rules can be different depending on the product what you're doing the company involved, where you are and the specific details. Check the government guidance and seek expert advice before altering any accounting or tax positions.
Build the Tax File Before Filing Season
If your business needs inventory support, activity-level reporting, COGS workpapers or tax-ready reconciliations CrownGlobes cannabis accounting services can help organize the accounting around the way the business actually operates. Book a consultation to review the records before the filing position is finalized.
